Management of pregnancy-associated breast cancer

Breast

Volumn 15, Issue SUPPL. 2, 2006, Pages

  Jones, Alison Louise ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTIEMETIC AGENT; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ESTROGEN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; PROGESTERONE; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

ABSENCE OF SIDE EFFECTS; AGE; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOMA; BREAST FEEDING; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CARCINOGENESIS; COMBINATION CHEMOTHERAPY; DRUG CONTRAINDICATION; DRUG SAFETY; DRUG WITHDRAWAL; FETUS MALFORMATION; GONAD DYSFUNCTION; HEART DISEASE; HUMAN; HYDRAMNIOS; INTRAUTERINE GROWTH RETARDATION; KIDNEY DYSFUNCTION; LACTATION; LEUKEMOGENESIS; LONG TERM EXPOSURE; MAMMOGRAPHY; NONHUMAN; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGNOSIS; SECOND TRIMESTER PREGNANCY; TERATOGENICITY; THIRD TRIMESTER PREGNANCY; THORAX RADIOGRAPHY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; BREAST NEOPLASMS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; PROGNOSIS;

EID: 33947254414     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(07)70018-8     Document Type: Article

References (29)

1. Wallack M., Wolff Jr. J., Bedwinek J., et al. Gestational carcinoma of the female breast. Curr Probl Cancer 7 (1983) 1-58
2. Barnavon Y., and Wallack M. Management of the pregnant patient with carcinoma of the breast. Surg Gynaecol Obstet 171 (1990) 347-352
3. Middleton L., Amin M., Gwyn K., et al. Breast cancer in pregnant women: assessment of clinical pathological and immunohistochemical features. Cancer 98 (2003) 1055-1060
4. Reed W., Hannisdal G., Skovlund F., et al. Pregnancy and breast cancer: a population-based study. Virchows Arch 443 (2003) 44-50
5. Elledge R., Ciocca D., Lagoneg, and Maguire W. Oestrogen-receptor, progesterone-receptor, and HER-2/neu protein in breast cancers from pregnant patients. Cancer 71 (1993) 2499-2506
6. Ives A., Saunders C., and Semmens J. The Western Australian Gestational Breast Cancer Project: a population-based study of the incidence, management and outcomes. Breast 14 (2005) 276-282
7. Zemlickis D., Lissner M., Degendorfer P., et al. Foetal outcome of intrautero exposure to cancer chemotherapy. Arch Intern Med 152 (1992) 573-576
8. Gelber S., Coates A., Goldhirsch A., et al. Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol 19 (2001) 1671-1675
9. Lowe S. Diagnostic radiography in pregnancy: risks and reality. Aust NZ J Obstet Gynaecol 44 (2004) 191-196
10. DeWilde A., Rivers A., and Price D. A review of the current use of magnetic resonance imaging in pregnancy and safety implications for the foetus. Prog Biophys Mol Biol 87 (2005) 335-353
11. Ravdin P., Siminoff L., Divis J., et al. Computer programme to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 19 (2001) 980-991
12. Olivotti I., Bajdik C., Ravdin P., et al. Populationbased validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 23 (2005) 2716-2725
13. Kelleher A., Wendt R., Delpassande, et al. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulphur colloid. Breast J 10 (2004) 492-495
14. Gentilini O., Cremonesi M., Trifiro G., et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 15 (2004) 1348-1351
15. Moran M., Colasanto J., Haffty B., et al. Effects of breast conserving therapy on lactation after pregnancy. Cancer J 11 (2005) 399-403
16. Green A., Styles J., Parrot E., et al. Neonatal tamoxifen of mice leads to adenomyosis but not uterine cancer. Exp Toxicol Pathol 56 (2005) 255-263
17. Isaacs R., Hunter W., and Clark K. Tamoxifen as systemic treatment of advanced breast cancer during pregnancycase report and literature review. Gynaecol Oncol 80 (2001) 405-408
18. Halakivi, Clarke L., Choe, Onojafei, et al. Paternal exposure to tamoxifen during pregnancy increases carcinogen-induced mammary tumorigenesis among female rat offspring. Clin Cancer Res 6 (2000) 305
19. Gwyn K., Theriault R., Sahina, et al. Treatment of breast cancer during pregnancy using a standardised protocol: update of the MD Anderson experience. Proc Am Soc Clin Oncol 20 (2001) 18B
20. Gwyn K, Taeriaul TR. Breast cancer during pregnancy 2001. Oncology; 39-46.
21. Ring A., Smith, Jones A., et al. Chemotherapy for breast cancer during pregnancy: an 18 year experience from five London teaching hospitals. J Clin Oncol 23 (2005) 4192-4197
22. Giacalone P., Laffargue F., and Benos P. Chemotherapy for breast cancer during pregnancy: a French national survey. Cancer 86 (1999) 2266-2272
23. Berry D., Theriault R., Holmes F., et al. Management of breast cancer during pregnancy using a standardised protocol. J Clin Oncol 17 (1999) 855-861
24. De Santis M., Lucchese A., De Carolis, et al. Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel. Eur J Cancer Care 9 9 (2000) 235-237
25. Gonzales-Angulo A., Walters R., Carpenter R., et al. Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin Breast Cancer 5 (2004) 317-319
26. Fanale M., Uyeiar, Theriault R., et al. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin Breast Cancer 6 (2005) 354-356
27. Watson W. Herceptin (Trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstet Gynaecol 105 (2005) 642-643
28. Toler J., Coad J., and Neglia J. Transplacental transfer of small cell carcinoma of the lung. N Eng J Med 346 (2002) 1501-1502
29. Aviles A., and Merri N. Haematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2 (2001) 173-177